Explore the latest advancements in liquid biopsy for oncology, examining current trends and insights that could shape future ...

Exploring the relationship between cancer cells and nerve cells, which can signal tumors to grow, could unearth ways to slow disease.

Air pollution is increasingly becoming a silent but deadly threat, particularly for urban non-smokers. Though active smoking ...

Lung cancer remains one of the deadliest cancers worldwide, with survival rates stubbornly low despite advances in surgery, ...

Having knowledge of the molecular characteristics of non-small cell lung cancer enhances understanding the disease, Dr. Fred R. Hirsch, Joe Lowe and Louis Price Professor of Medicine (Hematology and ...

Last year, state epidemiologists studied an industrialized region east of Houston. They reported finding high rates of cancer but refused to release key geographic details — a decision some experts ...

Researchers at the University of Oslo and Oslo University Hospital have developed a promising new immunotherapy targeting the ...

As lung cancer treatments evolve and more data are published, there is a need for updated recommendations on how to manage ...

Lung disease causes nearly 11% of deaths in India. And yet awareness and access to treatment remain poor. Myths and unequal healthcare widen the gap. Thoracic surgeon urges breaking misconceptions, ...

The FDA has approved Zepzelca with Tecentriq or Tecentriq Hybreza for extensive-stage small cell lung cancer.

Events listed for Wednesday, Oct. 8 ...

Extensive Validation of BioMark’s Comprehensive Metabolic Panel in German 10,000-Participant HANSE Study, within the context of an international consortium supported under the EUREKA Network.